(833) 317-6278
Book a Demo
Jacob White
Gray shield icon
Is this you?
Claim your profile.

Jacob White

AS SEEN ON
dcatvci.org, The Lion's Roar, MoneyWeek

Preston's Summary

Jacob White is a journalist whose work has appeared in publications such as FantasyPros and Gridiron Experts. He specializes in covering news and developments in the biopharmaceutical industry, including mergers and acquisitions, manufacturing updates, and partnering news. Jacob provides in-depth analysis and reporting on the latest happenings in the pharmaceutical world.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Press Release: 47 %
Private Sector Announcements: 43 %
Government Announcement: 4 %
Event Coverage: 1 %
Cites Data: 1 %

Themes Covered:

Most Recent Topics:

  • Biotechnology
  • FDA
  • Genetic Engineering
  • Oncology

Pitching Insights

Jacob White's articles primarily focus on press releases and private sector announcements related to the healthcare and pharmaceutical industry, with an emphasis on mergers and acquisitions. He frequently covers news about specific companies in the pharmaceutical industry, including their partnerships, manufacturing updates, and supplier relationships.

Given this focus, Jacob is likely to be interested in receiving pitches related to breaking news about mergers and acquisitions within the pharmaceutical industry or significant partnerships between major healthcare companies. Additionally, he may be open to receiving information about new developments from key suppliers or manufacturers within the sector.

Pitches should provide concise details of how a particular announcement or development contributes to broader trends within the healthcare and pharmaceutical landscape.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Alex Philippidis

Alex Philippidis

Senior Business Editor
**********is@***********com
Publications
Genetic Engineering & Biotechnology News
Most recent topics
Healthcare & Pharmaceutical, Scientific, Biotechnology, Sales & Marketing, Real Estate Industry
Neil Versel

Neil Versel

Editor, Informatics
******l@**********com
Publications
BioSpace
Most recent topics
Healthcare & Pharmaceutical, Data & Analytics, Biotechnology, Scientific, Tech
Dan Stanton

Dan Stanton

Editor
*********on@*********om
Publications
BioProcess International
Most recent topics
Healthcare & Pharmaceutical, Manufacturing, Biotechnology, Sustainability, Sales & Marketing
Millie Nelson

Millie Nelson

Publications
BioProcess International
Most recent topics
Healthcare & Pharmaceutical, Manufacturing, Sustainability, Biotechnology, Education
Joseph Keenan

Joseph Keenan

Publications
Fierce Pharma
Most recent topics
Healthcare & Pharmaceutical, Health, Manufacturing, Business, Scientific
Shreeyashi Ojha

Shreeyashi Ojha

Publications
BioProcess International
Most recent topics
Healthcare & Pharmaceutical, Sustainability, Manufacturing, Biotechnology, Business & Industry

Articles

WHO Official Says Mpox and COVID in Europe Not Comparable

By: Jacob White

At a press briefing in Geneva, Switzerland, earlier this week (August 20, 2024), Dr. Hans Kluge, the World Health Organization's (WHO) Regional Director for Europe, said that the risk from mpox to the general population in Europe was “low.”

Avantor To Sell Clinical Services Business to Audax Private Equity for $650 M

By: Jacob White

Avantor, a provider of products and services to the life sciences and advanced technologies industries, has agreed to divest its clinical services business, including kitting, biorepository, and related equipment and ancillaries, to Audax Private Equity, an investment firm, for approximately $650 million.

Supplier News: Bora, Recipharm, Olon & More

Supplier News: Bora, Recipharm, Olon & More

By: Jacob White

Supplier News: Bora, Recipharm, Olon & More The latest from CDMOs, CMOs, and suppliers featuring Bora Pharmaceuticals, Recipharm, Olon, Evotec, Renaissance Lakewood, Aenova, Rentschler Biopharma, Vetter, and Cardinal Health.

Partnering News: Lilly, Novartis, Pfizer & More

Partnering News: Lilly, Novartis, Pfizer & More

By: Jacob White

Partnering News: Lilly, Novartis, Pfizer & More A roundup of bio/pharmaceutical partnering news from Eli Lilly and Company/Haya Therapeutics, Novartis/Lindy Biosciences and Pfizer/Flagship Pioneering/Quotient Therapeutics.

Endo's CEO Departs; Names Interim CEO

By: Jacob White

The Board of Director of Endo, a Malvern, Pennsylvania-based specialty pharma and generics company, that the company's President and CEO, departed the company, effective August 29, 2024, and has named Scott Hirsch, currently a member of Endo's Board, as the company's Interim CEO. The company has initiated a search for a new CEO and Hirsch will continue to serve as Interim CEO during the transition period while the search is ongoing.

Pfizer, Moderna Get FDA OK for Updated COVID Vaccines

By: Jacob White

The US Food and Drug Administration (FDA) has granted approval to Pfizer/BioNTech and Moderna for their respective supplemental biologics license applications for their updated mRNA COVID-19 vaccines, tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage. The companies announced the approvals last month (August 22, 2024).

© 2024 Intelligent Relations